Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06950762

Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial

Using bioactive injectable resin composite in anterior class v carious lesions can provide better aesthetic outcome and marginal integrity by releasing multiple ions, including fluoride. This offers better marginal integrity due to presence of S-PRG fillers

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Restoration of Carious Class v Anterior Teeth

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 20-60 years.
  • Co-operative participants approving to participate in the study.
  • Male or female patients.
  • Medically free participants.
  • Moderate or high caries risk participants.

Exclusion criteria

  • Systemic disease or severe medical complications.
  • Participants with a history of allergy to any component of restorations will be used in the study.
  • Lack of compliance
  • Evidence of severe bruxism, clenching, or temporomandibular joint disorders or bizarre habits

Treatment and study plan

Giomer based injectable composite

Procedure

Giomers utilize surface pre-reacted glass (SPRG) technology, which involves an acid-base reaction between fluorine-containing glass particles and polymer-containing acid when exposed to water. This reaction results in the formation of a glass ionomer phase, which is then dispersed throughout the resin. Furthermore, the S-PRG fillers present in giomer materials enable the continuous release and replenishment of fluoride, offering long-lasting protection against the recurrence of caries

Universal injectable resin composite

Procedure

Conventional injectable resin composite

Primary outcomes

  1. Marginal discoloration using FDI criteria

    Time frame: 12 Month

Study contacts

Contact information is provided by the study sponsor or research team.

Abdelrhman Ahmed Elhariry, BDS

CONTACT

[email protected]

+201069630412

Sponsors and collaborators

Lead sponsor

Future University in Egypt

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 30, 2025
Registry last updated
Jun 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.